287 related articles for article (PubMed ID: 25659581)
1. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
4. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
5. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
[TBL] [Abstract][Full Text] [Related]
6. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
[TBL] [Abstract][Full Text] [Related]
7. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
8. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
Morlon A; Munnich A; Smahi A
Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
[TBL] [Abstract][Full Text] [Related]
9. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
[TBL] [Abstract][Full Text] [Related]
10. Stercurensin inhibits nuclear factor-κB-dependent inflammatory signals through attenuation of TAK1-TAB1 complex formation.
Kim YJ; Kim HC; Ko H; Amor EC; Lee JW; Yang HO
J Cell Biochem; 2011 Feb; 112(2):548-58. PubMed ID: 21268076
[TBL] [Abstract][Full Text] [Related]
11. The Us2 Gene Product of Herpes Simplex Virus 2 modulates NF-κB activation by targeting TAK1.
Lu X; Huang C; Zhang Y; Lin Y; Wang X; Li Q; Liu S; Tang J; Zhou L
Sci Rep; 2017 Aug; 7(1):8396. PubMed ID: 28827540
[TBL] [Abstract][Full Text] [Related]
12. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.
Wan YY; Chi H; Xie M; Schneider MD; Flavell RA
Nat Immunol; 2006 Aug; 7(8):851-8. PubMed ID: 16799562
[TBL] [Abstract][Full Text] [Related]
13. Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells.
Ota K; Kawaguchi M; Fujita J; Kokubu F; Huang SK; Morishima Y; Matsukura S; Kurokawa M; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Exp Lung Res; 2015; 41(6):335-43. PubMed ID: 26151454
[TBL] [Abstract][Full Text] [Related]
14. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
Ninomiya-Tsuji J; Kishimoto K; Hiyama A; Inoue J; Cao Z; Matsumoto K
Nature; 1999 Mar; 398(6724):252-6. PubMed ID: 10094049
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
16. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
Ear T; Fortin CF; Simard FA; McDonald PP
J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
[TBL] [Abstract][Full Text] [Related]
17. POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway.
Weng T; Koh CG
Cell Death Dis; 2017 Sep; 8(9):e3051. PubMed ID: 28906490
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
19. IFIT5 positively regulates NF-κB signaling through synergizing the recruitment of IκB kinase (IKK) to TGF-β-activated kinase 1 (TAK1).
Zheng C; Zheng Z; Zhang Z; Meng J; Liu Y; Ke X; Hu Q; Wang H
Cell Signal; 2015 Dec; 27(12):2343-54. PubMed ID: 26334375
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
Geurts J; van den Brand BT; Wolf A; Abdollahi-Roodsaz S; Arntz OJ; Kracht M; van den Berg WB; van de Loo FA
Rheumatology (Oxford); 2011 Jul; 50(7):1216-25. PubMed ID: 21335610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
